Zelgen (泽璟制药) is a pharmaceutical company focusing on the oncology, hematology, and gastroenterology areas. It develops molecule and recombinant protein drugs for liver cancer, non-small cell lung cancer, colorectal cancer, thyroid cancer, etc. The company also co-develops treatments of targeted small molecule drugs and anti-PD-1/PD-L1 antibodies.
|HQ||Suzhou Shi, CN||Map|
Zelgen total Funding
Zelgen latest funding size
Time since last funding
|4 years ago|
|Shenzhen Capital Group, Share Capital, Minsheng Life Insurance|
When was Zelgen founded?
Zelgen was founded in 2009.
Who are Zelgen competitors?
Competitors of Zelgen include Takeda Pharmaceutical, 3sbio and Shanghai Junshi Biosciences.
Where is Zelgen headquarters?
Zelgen headquarters is located at 209 Chenfeng Rd, Kunshan Shi, Suzhou Shi.
Where are Zelgen offices?
Zelgen has an office in Suzhou Shi.
How many offices does Zelgen have?
Zelgen has 1 office.
Receive alerts for 300+ data fields across thousands of companies